[236 Pages Report] Sales in the global Urology Imaging Systems Market are slated to top US$ 391.6 Mn in 2022. Expanding at a healthy 3.7% CAGR, the market size is projected to total US$ 486.4 Mn by 2028.
Attribute | Details |
---|---|
Urology Imaging Systems Market Estimated Size 2022 | US$ 391.6 Million |
Urology Imaging Systems Market Value-based CAGR (2022 to 2028) | ~3.7% |
Urology Imaging Systems Market Size in Projected 2028 | US$ 486.4 Million |
The rising prevalence of various urologic diseases, such as prostate problems, bladder control problems, kidney stones, and Urinary Tract Infections (UTI) is projected to boost the sales in this market. Coupled with this, the increasing cases of multiple sclerosis and Parkinson's disease amongst the geriatric population is set to drive the market in the upcoming years.
The ongoing development of handheld urology MRI scanners by various renowned manufacturers across the globe is estimated to spur the market. The market also will gain from the growing number of international resellers of refurbished and brand new urology imaging systems.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 3.78% |
H1, 2022 Projected | 3.68% |
H1, 2022 Outlook | 3.48% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) | (+) 04 ↑ |
BPS Change – H1, 2022 (O) – H1, 2021 | (-) 30 ↓ |
As per the Future Market Insights’ analysis, the H1-2022 outlook period in comparison to H1-2022 projected period showed a surge in growth rate in terms of Basis Point Share by 04 BPS.
The surge in the BPS values observed can be associated with the development of 3d printing for novel equipment, as well as translation of medical imaging into tangible replicas of patient-specific anatomy. With growing enhancements in medical imaging systems, the market is set to experience a positive growth outlook.
However, In H1-2022 when compared to H1-2021, the market growth rate of urology imaging systems is expected to fall by 30 basis point share (BPS), as per FMI analysis. The resultant drop in the BPS values in are associated with the high costs associated with the MRI compatible urology imaging systems, as well as long procedural time, thus resulting in a fall in the adoption rate.
The market is subject to changes as per the macro and industry dynamics which include disease prevalence and epidemiology, device regulations, technology adoption, and product licensing and distribution.
Key developments in the market include the collaboration of 3D printing and additive manufacturing for imaging.
The urology imaging systems market is expected to register 3.7% CAGR between 2022 and 2028, up from 3.8% CAGR recorded during 2013-2021, predicts Future Market Insights.
The increasing cases of kidney stones in various parts of the globe is one of the major factors bolstering the sales of urology imaging solutions. According to the National Kidney Foundation, from 2013 to 2014, the prevalence of kidney stones was 10% in the U.S., while in the late 2000s, it was 8.8%. It is likely to surge worldwide in the near future because of obesity, not drinking enough water, and consumption of sugar and protein-rich food and beverages.
Focus of various governments towards the expansion of their healthcare infrastructure also will fuel the demand for urology scanners. The market is slated to gain from the growing number of innovative diagnostic centers and the high prevalence of chronic diseases.
The increasing geriatric population is often linked to the surging prevalence of bladder outlet obstruction, urological cancer, and urinary incontinence. As per a report published by the World Health Organization (WHO) in 2017, the prevalence of urinary incontinence reported in population-based studies ranges from 9.9% to 36.1%. The rate is twice as high in older women as in older men. This trend is likely to continue in the near future, thereby propelling the growth in this market.
The surging adoption of cutting-edge urology imaging solutions by non-radiologists is projected to push the growth in this market. Innovations in PC-based designs, miniaturization of ultrasound urology imaging systems, development of the narrow band imaging cystoscopy technology, and the easy access to instant clinical information are estimated to fuel the market in the forthcoming years.
Stone formation and infections in the tract are the two common urological diseases that are expected to increase in the future backed by the high consumption of red meat and alcohol, drinking inadequate amount of water, and lack of knowledge about urological hygiene post sexual intercourse.
The WHO mentioned that an estimated 50% of women report having had an UTI at some point in their lives and more than 1 million hospitalizations take place every year because of this condition worldwide. Thus, governments around the world are taking initiatives to conduct awareness programs to educate the general public about UTI and its treatment options, which is set to bolster the demand for urology imaging solutions.
“Rapid Adoption of Portable Urology Scanners to Drive the Market”
The rising adoption of portable urology scanners among non-radiology specialists in the U.S. is anticipated to drive the urology imaging systems market in North America. Also, the presence of various reputed healthcare device manufacturers, such as GE, Stryker Corporation, Boston Scientific Corporation, and Intuitive Surgical in the U.S. is projected to accelerate adoption of urology imaging systems.
In December 2021, for instance, Proton International, a leading provider of proton therapy to cancer patients based in Florida, signed a new contract with Belgium-based medical technology company, Ion Beam Applications S.A. As per this contract, Ion will install the former’s Proteus ONE proton therapy solution in its three-story Radiation Oncology Center.
The system will be equipped with a fully integrated Quality Assurance (QA) hardware and software package, Pencil Beam Scanning (PBS), hand pendant for easy patient positioning, and Cone Beam Computed Tomography (CBCT). Thus, the engagement of leading U.S.-based players in signing contracts with healthcare institutions of other countries is anticipated to spur the demand for urology scanners.
“Growing Incidence of Prostate Cancer to Boost Adoption of Narrow Band Imaging Cystoscopy”
The rapid expansion of the medical devices industry in Japan is likely to bolster the urology imaging systems market in East Asia during the evaluation period. The country has the highest number of the elderly population in this region. According to the World Bank data, in 2020, about 28.39% percent of Japan's population were aged 65 years and above. This number is projected to surge in the forthcoming years, thereby propelling the need for urology MRI scans.
Furthermore, the higher incidence rate of colorectal cancer and prostate cancer among the aging population is set to spur the market in Japan. The American Association for Cancer Research states that the incidence of prostate cancer surged to 58.7 in 2014 from 7.1 per 100,000 in 1975 in Japan. Driven by the abovementioned factors, the adoption of narrow band imaging cystoscopy technology is likely to grow in this country.
“Increasing Obese Population to Fuel the Demand for Urology MRI Scanners”
The increasing demand for cloud-based solutions with higher magnified visualization and portable urology MRI scanners equipped with novel software solutions in the U.K. is set to push the growth in Europe by 2028. Besides this, the presence of a well-established healthcare system in the U.K. is estimated to propel the market in the near future.
The increasing cases of obesity owing to the surging consumption of junk food and adoption of unhealthy lifestyles is anticipated to spur the market in the U.K. According to Cancer Research U.K., 1 in 6 men will get prostate cancer at some point in their lives in this country. The organization also mentions that being obese will increase the risk of advanced prostate cancer. Thus, the prevalence of prostate cancer induced by obesity is set to rise in the U.K., which would bolster the market.
“High Accuracy Feature to Fuel Demand for Ultrasound Urology Imaging Solutions”
In terms of product type, the ultrasound systems segment is estimated to account for approximately 54.6% of the urology imaging systems market share in 2022, predicts FMI. The high reliability and accuracy provided by ultrasound systems in terms of diagnosis is anticipated to propel their demand in the assessment period.
The fluoroscopy-based systems will remain the second-leading segment, contributing around 45.4% of the market share till 2022, finds FMI. Unlike standard radiographs, fluoroscopy-based systems deliver images in an inverted grayscale. The ongoing evolution in the field of urology imaging solutions is projected to aid the development of advanced fluoroscopy-based systems with 3-D capabilities. This is likely to spur the segment’s growth.
“Hospitals are Preferring Narrow Band Imaging Cystoscopy Technology”
Based on end user, the hospitals segment is anticipated to remain at the forefront in terms of the urology imaging systems market share. The surging demand for minimally invasive techniques owing to the need to shorten the length of hospital stay, reduce the infection rate, and lower the blood loss across the globe is likely to increase people’s preference for hospitals.
The increasing number of hospitals offering state-of-the-art medical services, such as narrow band imaging cystoscopy technology in both developed and emerging economies is expected to push the segment forward. Many renowned companies are tying up with hospitals worldwide to install their in-house solutions for providing better treatment options to patients. This will also emerge as a chief growth driver.
Some of the key players operating in the urology imaging systems market are focusing on the production of novel systems to cater to the high demand from patients across the globe. Other players are conducting extensive research and development activities to introduce technologically developed urology imaging solutions. A few of them are also participating in the acquisition strategy to expand their existing product portfolios and gain a competitive edge in the market.
For instance,
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Forecast Period | 2013 to 2021 |
Historical Data Available for | 2022 to 2028 |
Market Analysis | Units for Volume and US$ Mn for Value |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; India; and the Middle East & Africa. |
Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
Key Market Segments Covered | Product Type, End Use, and Region |
Key Companies Profiled | Philips Healthcare; GE Healthcare; Siemens Healthcare; Analogic Corporation; Esaote S.p.A.; Samsung Medison Co. Ltd.; FUJIFILM Holdings Corporation; Hitachi Medical Corporation; Toshiba Corporation; Mindray Medical International Limited |
Pricing | Available upon Request |
By Product Type:
By End User:
By Region:
The global urology imaging systems market is expected to reach a valuation of US$ 391.6 Mn in 2022.
The global urology imaging systems market grew at a healthy 3.8% CAGR between 2013 and 2021.
The increasing prevalence of prostate cancer and the rising demand for minimally invasive techniques are the key trends boosting the sales of urology imaging systems.
Philips Healthcare, GE Healthcare, Siemens Healthcare, Analogic Corporation, Esaote S.p.A., Samsung Medison Co. Ltd., FUJIFILM Holdings Corporation, and Hitachi Medical Corporation are some of the leading players present in the global urology imaging systems market.
The ultrasound systems segment is anticipated to account for 54.6% of the urology imaging systems market share in 2022.
The fluoroscopy-based systems segment is projected to account for 45.4% of the urology imaging systems market share in the forecast period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies
5. Global Market - Comparative Analysis
5.1. Regional Comparative Analysis By Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028
6.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Gross Domestic Product by Region & Country,
7.1.2. Global Medical Devices Industry Market Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Top Companies & their Historical Growth
7.2.2. Technology Innovation in Urology Imaging Systems
7.2.3. Penetration of Products in Different Distribution Channel
7.2.4. Regulatory Imposition on Production
7.2.5. R&D Investment for Products
7.2.6. Annual Installs
7.3. Value Chain
7.3.1. Manufacturers
7.3.2. Distributors/Suppliers/Wholesalers
7.3.3. End Users
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Opportunity Analysis
8. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2013 - 2021
8.3. Current and Future Market Size (US$ Mn) and Volume Analysis (Units) and Forecast By Product Type, 2022 - 2022
8.3.1. Ultrasound Systems
8.3.2. Fluoroscopy Based Systems(Conventional radiology)
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2013-2021 and Forecast 2022-2028, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2013 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2022
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Diagnosis Centers
9.3.4. Clinics
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2022
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2013-2021 and Forecast 2022-2028
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By End User
11.5. Market Attractiveness Analysis
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
12. Latin America Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product Type
12.4.3. By End User
12.5. Market Attractiveness Analysis
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
13. Europe Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. BENELUX
13.4.1.7. Russia
13.4.1.8. Rest of Europe
13.4.2. By Product Type
13.4.3. By End User
13.5. Market Attractiveness Analysis
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. South Asia Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
14.4.1. By Country
14.4.1.1. India
14.4.1.2. Thailand
14.4.1.3. Indonesia
14.4.1.4. Malaysia
14.4.1.5. Rest of South Asia
14.4.2. By Product Type
14.4.3. By End User
14.5. Market Attractiveness Analysis
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.4.3. By End User
15.5. Market Attractiveness Analysis
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Oceania Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
16.4.1. By Country
16.4.1.1. Australia
16.4.1.2. New Zealand
16.4.2. By Product Type
16.4.3. By End User
16.5. Market Attractiveness Analysis
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. Northern Africa
17.4.1.3. South Africa
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product Type
17.4.3. By End User
17.5. Market Attractiveness Analysis
17.7. Drivers and Restraints - Impact Analysis
18. Emerging Countries Market Analysis 2013-2021 and Forecast 2022-2028
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Urology Imaging Systems Market Analysis
18.2.1. Introduction
18.2.2. Pricing Analysis
18.2.3. PEST Analysis
18.2.4. Market Value Proportion Analysis by Market Taxonomy
18.2.5. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.5.1. By Product Type
18.2.5.2. By End User
18.2.6. China Urology Imaging Systems Market - Competition Landscape
18.2.7. China - Trade Analysis
18.3. India Urology Imaging Systems Market Analysis
18.3.1. Introduction
18.3.2. Pricing Analysis
18.3.3. PEST Analysis
18.3.4. Market Value Proportion Analysis by Market Taxonomy
18.3.5. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.3.5.1. By Product Type
18.3.5.2. By End User
18.3.6. India Urology Imaging Systems Market - Competition Landscape
18.3.7. India - Trade Analysis
18.4. Mexico Urology Imaging Systems Market Analysis
18.4.1. Introduction
18.4.2. Pricing Analysis
18.4.3. PEST Analysis
18.4.4. Market Value Proportion Analysis by Market Taxonomy
18.4.5. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.5.1. By Product Type
18.4.5.2. By End User
18.4.6. Mexico Urology Imaging Systems Market - Competition Landscape
18.4.7. Mexico - Trade Analysis
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. By Regional footprint of Players
19.3.2. Product foot print by Players
19.3.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Pricing Analysis by Competition
20.3. Competition Benchmarking
20.4. Competition Deep Dive
20.4.1. Philips Healthcare
20.4.2. GE Healthcare
20.4.3. Siemens Healthcare
20.4.4. Analogic Corporation
20.4.5. Esaote S.p.A.
20.4.6. Samsung Medison Co. Ltd.
20.4.7. FUJIFILM Holdings Corporation
20.4.8. Mindray Medical International Limited
20.4.9. Toshiba Corporation
20.4.10. Hitachi Medical Corporation
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports